MAKO

Banking on Buyouts in Biotech: Is It Smart?

Unless you really understand medicine, it's a very risky game. The chances of a little company scoring big and getting bought out are usually slim. More 

Tech Takes Over the Market — Wednesday’s IP Market Recap

Tech stocks rallied despite a warning from Intel, leading the Nasdaq to gains of more than 1%, and eBay, IBM and Qualcomm were on the rise late. More 

Swing for the Fences With These 5 Biotech Stocks

If you're prepared for the very high stakes and high risks of biotech investing, these five biotech stocks might be worth your while. More 

Fed Minutes Spark a Selloff — Wednesday’s IP Market Recap

Investors hoping for a sign of economic stimulus or easing from the Fed were let down Wednesday, putting a cramp on equities. More 

Beatings Doled Out Sectorwide — Tuesday’s IP Market Recap

Earnings warnings and a bankruptcy filing caused upheaval Tuesday among coal companies, chipmakers and engine manufacturers. More 

MAKO Surgical: Kneecapped on Sales Shortfall — Again

A great product in a great market doesn't automatically equal great profits and share-price performance. More 

Ranking InvestorPlace’s 10 Best Stocks for 2012 Through Q2

A rough Q2 has shaken our 10 expert picks, but more than half still are in the black through the first half of 2012. Here's how our picks rank after six months. More